GPX7: A Potential Drug Target and Biomarker (G2882)

Target Name: GPX7

NCBI ID: G2882

GPX7

GPX7: A Potential Drug Target and Biomarker

GPX7 is a protein that is expressed in the human placenta, and it has been shown to play a critical role in the development and maintenance of pregnancy. The placenta is a vital organ that supports the growth and development of fetal tissues, and it is responsible for providing the fetal child with essential nutrients and oxygen. GPX7 helps to regulate the growth and differentiation of the placenta, and it has been shown to be involved in a number of important physiological processes that are necessary for pregnancy.

One of the key functions of GPX7 is its role in cell signaling. GPX7 is a G protein-coupled receptor (GPCR), and it is involved in the regulation of a wide range of cellular processes, including cell growth, differentiation, and survival. GPX7 has been shown to play a key role in the regulation of placental angiogenesis, which is the process by which the placenta develops and forms blood vessels to supply it with oxygen and nutrients.

In addition to its role in cell signaling, GPX7 is also involved in the regulation of inflammation. Placenta is a site of inflammation and also a site of protection for the fetal tissue. GPX7 has been shown to play a critical role in the regulation of inflammation in the placenta, and it has been shown to be involved in the production of pro-inflammatory cytokines.

Another function of GPX7 is its role in cell survival. GPX7 is involved in the regulation of cell survival and proliferation, and it has been shown to play a key role in the regulation of cell cycle progression. This is important for the regulation of cell growth and for the development of cancer.

GPX7 is also involved in the regulation of angiogenesis and blood vessel formation. Angiogenesis is the process by which new blood vessels are formed in the body, and it is important for the development and maintenance of tissues. GPX7 is shown to be involved in the regulation of angiogenesis, and it has been shown to play a critical role in the formation of new blood vessels in the placenta.

In addition to its role in cell signaling, GPX7 is also involved in the regulation of inflammation. Placenta is a site of inflammation and also a site of protection for the fetal tissue. GPX7 has been shown to play a critical role in the regulation of inflammation in the placenta, and it has been shown to have anti-inflammatory effects.

GPX7 is also involved in the regulation of cell survival and proliferation. GPX7 is shown to be involved in the regulation of cell cycle progression, and this is important for the regulation of cell growth and for the development of cancer.

In conclusion, GPX7 is a protein that plays a critical role in the development and maintenance of pregnancy. It is involved in cell signaling, inflammation, and cell survival and proliferation. As a result, GPX7 is a potential drug target and biomarker for a variety of diseases. Further research is needed to fully understand the role of GPX7 in pregnancy and its potential as a drug.

Protein Name: Glutathione Peroxidase 7

Functions: It protects esophageal epithelia from hydrogen peroxide-induced oxidative stress. It suppresses acidic bile acid-induced reactive oxigen species (ROS) and protects against oxidative DNA damage and double-strand breaks

The "GPX7 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about GPX7 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets